ClinConnect ClinConnect Logo
Search / Trial NCT06849895

Real-World Study of Myopia Prevention and Control in Children

Launched by SHANGHAI EYE DISEASE PREVENTION AND TREATMENT CENTER · Feb 23, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Myopia Premyopia Outdoor Activities Myopia Prevention Myopia Control Children Compliance Defocus Optical Lenses

ClinConnect Summary

This clinical trial is looking at ways to prevent and control myopia, also known as nearsightedness, in children. The study will involve around 15,000 primary school students in Shanghai, China, and aims to see how different strategies, like spending more time outdoors and wearing specially designed glasses or contact lenses, can help reduce the risk of developing myopia or slow down its progression. Researchers want to understand how effective these interventions are and what factors might influence their success.

To participate in the study, children need to be enrolled in the selected schools and able to complete eye exams with the help of their parents or guardians, who must provide written consent. However, children with certain eye conditions or systemic health issues that could affect their eyesight won't be eligible. Throughout the study, participants will be monitored to see how their vision changes, and the researchers will also evaluate the cost-effectiveness of the interventions to find the best approaches for wider use in schools.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. All students from the enrolled schools;
  • 2. Participants must be able to cooperate with and complete all required ophthalmic examinations;
  • 3. Written informed consent must be obtained from their parents or legal guardians.
  • Exclusion Criteria:
  • 1. Ocular abnormalities (e.g., strabismus, amblyopia, or other significant eye diseases);
  • 2. Systemic diseases that may affect ocular health;
  • 3. Current participation in other myopia intervention programs.

About Shanghai Eye Disease Prevention And Treatment Center

The Shanghai Eye Disease Prevention and Treatment Center is a leading clinical research organization dedicated to advancing the understanding and treatment of ocular diseases. With a strong emphasis on innovation and patient-centered care, the center collaborates with various stakeholders, including academic institutions and healthcare providers, to conduct rigorous clinical trials. Its mission is to enhance eye health outcomes through evidence-based research, contributing to the global body of knowledge in ophthalmology. The center is committed to fostering a culture of excellence in clinical practices, ensuring the highest standards of safety and efficacy in all its research endeavors.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported